| British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE MEJ Callister, DR Baldwin, AR Akram, S Barnard, P Cane, J Draffan, ... Thorax 70 (Suppl 2), ii1-ii54, 2015 | 807 | 2015 |
| Guidelines on the radical management of patients with lung cancer E Lim, D Baldwin, M Beckles, J Duffy, J Entwisle, C Faivre-Finn, K Kerr, ... Thorax 65 (Suppl 3), iii1-iii27, 2010 | 670 | 2010 |
| European position statement on lung cancer screening M Oudkerk, A Devaraj, R Vliegenthart, T Henzler, H Prosch, CP Heussel, ... The Lancet Oncology 18 (12), e754-e766, 2017 | 603 | 2017 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 482 | 2021 |
| Recent advances in the management of lung cancer GS Jones, DR Baldwin Clinical Medicine 18 (Suppl 2), s41, 2018 | 393 | 2018 |
| UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening JK Field, SW Duffy, DR Baldwin, DK Whynes, A Devaraj, KE Brain, ... Thorax 71 (2), 161-170, 2016 | 371 | 2016 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 289 | 2022 |
| The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. JK Field, SW Duffy, DR Baldwin, KE Brain, A Devaraj, T Eisen, BA Green, ... Health technology assessment (Winchester, England) 20 (40), 1, 2016 | 282 | 2016 |
| Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic … N Navani, M Nankivell, DR Lawrence, S Lock, H Makker, DR Baldwin, ... The Lancet Respiratory Medicine 3 (4), 282-289, 2015 | 274 | 2015 |
| Azithromycin concentrations at the sites of pulmonary infection DR Baldwin, R Wise, JM Andrews, JP Ashby, D Honeybourne European Respiratory Journal 3 (8), 886-890, 1990 | 270 | 1990 |
| PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer M Schmidt‐Hansen, DR Baldwin, E Hasler, J Zamora, V Abraira, ... Cochrane Database of Systematic Reviews, 2014 | 268 | 2014 |
| UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer DR Baldwin, SW Duffy, NJ Wald, R Page, DM Hansell, JK Field Thorax 66 (4), 308-313, 2011 | 264 | 2011 |
| The British Thoracic Society guidelines on the investigation and management of pulmonary nodules DR Baldwin, MEJ Callister Thorax 70 (8), 794-798, 2015 | 232 | 2015 |
| International association for the study of lung cancer computed tomography screening workshop 2011 report JK Field, RA Smith, DR Aberle, M Oudkerk, DR Baldwin, D Yankelevitz, ... Journal of Thoracic Oncology 7 (1), 10-19, 2012 | 218 | 2012 |
| Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit HA Powell, LJ Tata, DR Baldwin, RA Stanley, A Khakwani, RB Hubbard Thorax 68 (9), 826-834, 2013 | 195 | 2013 |
| Pulmonary disposition of antimicrobial agents: methodological considerations DR Baldwin, D Honeybourne, R Wise Antimicrobial agents and chemotherapy 36 (6), 1171-1175, 1992 | 190 | 1992 |
| Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial N Ali, KJ Lifford, B Carter, F McRonald, G Yadegarfar, DR Baldwin, ... BMJ open 5 (7), e008254, 2015 | 177 | 2015 |
| Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance DR Baldwin, D Honeybourne, R Wise Antimicrobial agents and chemotherapy 36 (6), 1176-1180, 1992 | 150 | 1992 |
| Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis HA Powell, B Iyen-Omofoman, DR Baldwin, RB Hubbard, LJ Tata Journal of Thoracic Oncology 8 (1), 6-11, 2013 | 147 | 2013 |
| The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening FE McRonald, G Yadegarfar, DR Baldwin, A Devaraj, KE Brain, T Eisen, ... Cancer Prevention Research 7 (3), 362-371, 2014 | 143 | 2014 |
